Clinical trial · Interventional
National Wilm's Tumor Study Late Effects
NCT00228696CI-TRIAL-00012747withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): national study, local site not responsible for results/analysis
Summary
Brief summary (as posted)
The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Patients must have been enrolled on the NWTS-5 protocol in order to be eligible for this study.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Wilm's Tumor | Wilms Tumor | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| none, screening only | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- NO_INTERVENTION
- label
- screening
- description
- this is a screening study and no intervention.
- interventionNames
- Other: none, screening only
Primary outcomes (1)
- measure
- To determine if survivors from Wilms tumors or their offspring are at risk for adverse medical conditions.
- timeFrame
- 1 year after closure of study
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: Previously enrolled in NWTS 5.
References
Publications (0)
Data not yet available
No reference posted for this study.